Treating Opioid Use Disorder in the Hospital_On Demand

This will be an interactive online program geared toward hospitalists about how to treat opioid use disorder in hospitalized patients.

**PLEASE NOTE: to claim MOC credit for this activity, after completion of the activity and evaluation, you will need to go to the evaluation page and click "Claim MOC."**

1. Summarize how to treat opioid use disorder in the hospital with buprenorphine, methadone, and depot naltrexone
2. Describe the resources available to support patients with opioid use disorder in the local community
3. Discuss the appropriate referral process of patients to outpatient treatment with buprenorphine, methadone, or depot naltrexone upon hospital discharge

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours), Act 13 Patient Safety/Risk Management Credits (1.00 hours), Act 124 Opioid Continuing Education Qualified (1.00 hours), ABS CC SAM (1.00 hours)

Wednesday, December 7, 2022, 10:00 AM - Tuesday, December 31, 2024, 11:59 PM

Accreditation Statement: WellSpan Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians. 

Credit Designation: WellSpan Health designates this Enduring Material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All faculty participating in continuing medical education programs sponsored by WellSpan Health are expected to disclosure to the program audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).

Mitigation of Relevant Financial Relationships

WellSpan Health CME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.